http://www.cyclacel.com
Cyclacel Pharmaceuticals, Inc. Company Intro
Cyclacel is a biopharmaceutical company, based in Berkeley Heights, New Jersey and Dundee, Scotland, that develops orally available small molecule drugs which target various cell cycle phases to control cancer and other serious diseases.
Industry
Healthcare
Cyclacel Pharmaceuticals, Inc. Headquaters
200 Connell Drive
Berkeley Heights,07922
United States
Cyclacel Pharmaceuticals, Inc. Share price
14 Sep 2022 09:02 GMT
$1.5800
-0.05 (-3.07 %)
Cyclacel Pharmaceuticals, Inc. Market cap
$15.86 M
WMC RANKING
2023
Cyclacel Pharmaceuticals, Inc. # 311
BiotechnologyLatest Cyclacel Pharmaceuticals, Inc. News
29 Mar 2023
StockNews.com Begins Coverage on Cyclacel ...
Cyclacel Pharmaceuticals, Inc is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology...
29 Mar 2023
StockNews.com Begins Coverage on Cyclacel ...
Cyclacel Pharmaceuticals, Inc is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology...
29 Mar 2023
StockNews.com Begins Coverage on Cyclacel ...
Cyclacel Pharmaceuticals, Inc is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology...
WMC Market Score
WMC Market to Revenue Score
Cyclacel Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cyclacel Pharmaceuticals, Inc. | USD | $0 | $12,517 | $-14,679 | $159M | 311 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cyclacel Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Cyclacel Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Cyclacel Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Cyclacel Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cyclacel Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cyclacel Pharmaceuticals, Inc. | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
